GSA Capital Partners’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-89,651
| Closed | -$82K | – | 1933 |
|
|
2025
Q1 | $82K | Buy |
+89,651
| New | +$82K | 0.01% | 1521 |
|
|
2024
Q4 | – | Sell |
-35,402
| Closed | -$185K | – | 1802 |
|
|
2024
Q3 | $185K | Sell |
35,402
-5,529
| -14% | -$28.9K | 0.01% | 1427 |
|
|
2024
Q2 | $183K | Sell |
40,931
-90,167
| -69% | -$403K | 0.01% | 1470 |
|
|
2024
Q1 | $1M | Sell |
131,098
-35,906
| -22% | -$275K | 0.08% | 432 |
|
|
2023
Q4 | $711K | Buy |
167,004
+74,358
| +80% | +$317K | 0.06% | 581 |
|
|
2023
Q3 | $389K | Buy |
92,646
+65,842
| +246% | +$276K | 0.03% | 944 |
|
|
2023
Q2 | $149K | Buy |
+26,804
| New | +$149K | 0.01% | 1339 |
|